组蛋白乙酰化酶对心脏发育核心转录因子Mef2c的动态调控作用

目的 观察心脏发育过程中组蛋白乙酰化酶P300、PCAF、SRC1对心脏发育核心转录因子Mef2c的动态修饰作用,为明确先天性心脏病的发生机制奠定基础。方法 选取胎龄14.5 d和16.5 d胎鼠及生后0.5 d和7 d小鼠的正常心脏组织,采用染色质免疫共沉淀技术,运用抗P300、PCAF、SRC1、乙酰化组蛋白（ac-H3）抗体免疫沉淀与其相结合的DNA,Real-Time-PCR扩增抗体所富集的DNA,观察小鼠心脏发育过程中Mef2c启动子区域组蛋白乙酰化酶的动态修饰及ac-H3水平;同时运用Real-Time-PCR检测Mef2c mRNA表达量。结果 小鼠心脏发育过程中P300、PCAF、SRC1均参与Mef2c启动子区域的乙酰化修饰,其结合水平在心脏发育的不同阶段差异均有统计学意义（均PPP结论 小鼠心脏发育过程中Mef2c基因呈现动态表达,提示Mef2c基因在心脏发育中具有重要作用;同时Mef2c启动子区域乙酰化水平的变化受组蛋白乙酰化酶P300、PCAF、SRC1的动态调控。

Temporal regulation of transcription factor Mef2c by histone acetylases during cardiogenesis

Objective To observe the temporal modification of transcription factor Mef2c by histone acetylases (HATs) P300, PCAF, and SRC1 during cardiogenesis and to provide a basis for investigating the pathogenesis of congenital heart disease. Methods The normal heart tissues from embryonic mice (embryonic days 14.5 and 16.5) and neonatal mice (postnatal days 0.5 and 7) were collected. The binding of P300, PCAF, and SRC1 to Mef2c gene and level of histone H3 acetylation in the promoter region of Mef2c were evaluated by chromatin immunoprecipitation assays. Meanwhile, real-time PCR was used to measure the mRNA expression of Mef2c. Results P300, PCAF, SRC1 were involved in histone acetylation in the promoter region of Mef2c during cardiogenesis in mice, and binding of P300, PCAF, and SRC1 to the promoter of Mef2c varied significantly in different stages of cardiogenesis (P<0.01). The level of histone H3 acetylation and mRNA expression of Mef2c in the promoter region of Mef2c also varied significantly in different stages of cardiac development (P<0.01). The levels of acetylated H3, Mef2c mRNA, and HATs (P300, PCAF, SRC1) changed over time. They were highest on embryonic day 14.5 (P<0.01), decreased gradually with cardiac development, and were maintained at low levels after birth. Conclusions The mRNA expression of Mef2c varies during cardiogenesis in mice, which indicates that Mef2c plays an important role in the process of cardiac development. Meanwhile, histone acetylation in the promoter region of Mef2c is regulated temporally by HATs P300, PCAF, and SRC1.